ClevesA

There’s a quiet shift happening PPIs used to be routine alongside steroids Now clinicians are asking why If there’s no clear benefit and real downside risk should we be using them at all? 🎧 Listen: docwirenews.com/post/medicatio… ‌ @RickyFrazer1 @AOlssonBrown #ImmunoOncology #MedicationSafety #Healthcare

Day 2 of the Immuno-Oncology Clinical Network national meeting in London continues with productive discussions focused on shaping a National Framework for the comprehensive management of immune-related adverse events (irAEs) associated with immune checkpoint inhibitor immunotherapies. Over the past two days, Clinicians Pharmacists and Nurses from across the UK have collaborated to share expertise, identify priorities, and explore how we can deliver safer, more consistent care for patients receiving immunotherapy treatments. Our collective goal remains clear: to maximise the benefits of immunotherapy while reducing the risk of serious toxicity and improving outcomes for patients nationwide. Thank you to everyone contributing their time, expertise, and commitment to this important work. #Immunotherapy #ImmunoOncology #PatientSafety #CancerCare #irAEs #HealthcareCollaboration #Oncology #IOCN @AOlssonBrown @Youngdr100 @JohnsonA_D @UKONSmember @BOPACommittee @immunobuddies @NHSEngland @nhs

🎙️ New Immunobuddies Episode Available! Episode 196: The Role of Supportive Care in Optimising Immunotherapy and Cancer Outcomes – Part 1 In this latest episode, we’re joined by Dr Dan Monnery from the Clatterbridge Cancer Centre to discuss the evolving role of supportive care in cancer treatment and immunotherapy. The conversation explores key aspects of patient support, multidisciplinary care, and approaches that can help improve patient experience and outcomes throughout treatment. 🎧 Tune in now to hear the discussion. buzzsprout.com/2128662/episod… @RickyFrazer1 @AOlssonBrown @VelindreCS @CCCNHS @IOClinicalNet @immunobuddies @UKAOSociety @UKONSmember @BOPACommittee @oncodaily @OncoDailyIO @onctrainees @ONCOassist @OncoViews @OncEd @OncologyNT @myESMO @ASCO @OncoAlert #Immunobuddies #Immunotherapy #SupportiveCare #CancerCare #Oncology #CancerOutcomes #HealthcarePodcast #MedEd #Clatterbridge #IOCN

📢 Today, we have made the decision to step down the universal mask-wearing across VCS. We would like to extend our sincere thanks to all staff and patients for your cooperation and commitment to mask-wearing over recent months 💚

🎧 NEW PODCAST EPISODE – PART 1 OF 4 We’re kicking off a brand-new 4-part series on the Impact of Diet on Immunotherapy in the latest episode of the Immunobuddies Podcast. In Part 1, we’re joined by Immunotherapy Dietician Raiatea Van-Reenen (University Hospital Derby) to explore: 🥗 How diet interacts with the immune system 🦠 The role of the gut microbiome in immunotherapy 🧠 What the evidence really says (and what it doesn’t) 🩺 Practical, patient-centred dietary approaches during treatment This series will break down nutrition, immunotherapy, and real-world clinical practice in a clear and practical way for healthcare professionals and patients alike. 🎙️ Listen now and stay tuned for Parts 2–4 coming soon. tinyurl.com/y6cszkcb @AOlssonBrown @RickyFrazer1 @UHDBTrust @IOClinicalNet @immunobuddies @myESMO @ASCO @BOPACommittee @UKONSmember @UKAOSociety @oncodaily @OncoDailyIO @onctrainees @ONCOassist @OncoViews @VelindreCS @OncEd @OncologyNT #Immunobuddies #Immunotherapy #Dieticians #OncologyNutrition #Microbiome #CancerCare #AlliedHealthProfessionals #PodcastSeries

🎟️Places are filling quickly for our next Case Conundrums Study Day in Bristol on March 27th 2026! Book now to avoid disapointment! 🎓🧬 🔗ticketsource.co.uk/immuno-oncolog…

🎙️ New Immunobuddies Mini-Series: Real-World Complex Cases 🚨 Ever wondered how experts navigate the trickiest immunotherapy scenarios in practice? 💭❓ Join Dr Ricky Frazer, Dr Anna Olsson-Brown, and guest Dr Jay Naik as they unpack real patient cases from the front line of immuno-oncology. In this six-part special, the team explores: ⚖️ How to approach diagnostic uncertainty in immune-related toxicity 🧩 Lessons learned from complex, real-world decisions 🤝 The importance of multidisciplinary teamwork in patient care These short, case-based episodes (around 20 minutes each) offer practical, honest insights you can apply in clinic — perfect for your next commute or coffee break ☕ 🎧Catch-up on episodes now: Episode 1: tinyurl.com/27vmmtnv Episode 2: tinyurl.com/4ddbpbhu Episode 3: tinyurl.com/2c645a9t #Immunobuddies #ImmunoOncology #Immunotherapy #MedicalPodcast #OncologyEducation #irAEs #CancerCare #ClinicalLearning @RickyFrazer1 @AOlssonBrown @IOClinicalNet @UKONSmember @UKAOSociety @BOPACommittee @myESMO @ASCO @ONCOassist @OncoViews @VelindreCS @HarrogateNHSFT @OncEd @OncologyNT

🚨🔊 New Podcast Episode – Immunobuddies Ep.159 🎙️ Triple Negative Breast Cancer: Role of Complete Pathological Response & Impact on Surgery In this episode, we dive into: ✅ Why complete pathological response (pCR) matters in TNBC ✅ The challenges of toxicity and prolonged neutropenia on surgical planning ✅ Can some patients be cured with systemic therapy alone – and what does the future hold? ✅ The critical role of multidisciplinary decision-making to balance treatment, toxicity, and surgery 💡 Surgery remains the cornerstone of cure – but emerging data and patient experiences are pushing us to rethink pathways and future research. Listen now 👉buzzsprout.com/2128662/episod… #Immunobuddies #BreastCancer #Immunotherapy #Oncology #TripleNegativeBreastCancer #OncoTwitter #ImmunoOncology #Cancer #TNBC @RickyFrazer1 @AOlssonBrown @IOClinicalNet @UKONSmember @UKAOSociety @BOPACommittee @CRUKCamBreast @OncEd @OncologyNT @BreastCaupdates @BreastCaConnect @bctrcg @NHSBartsHealth @VelindreCS @myESMO @ASCO @ONCOassist @OncoViews

🚨Join us for our next study day! 🧠Advancing the management of Immunotherapy Toxicities through Case Conundrums! 🗓️ Friday 3rd October 2025 | Birmingham 📷 6.5 CPD hrs | £150 🎓 Get your tickets here: tinyurl.com/kw3jce9k Or Contact Us: ioclinicalnetwork.co.uk/contact-us/ @AOlssonBrown @RickyFrazer1 @brentocarrigan @will_oncology @Youngdr100 @immunobuddies @UKONSmember @UKAOSociety @ACPUK @BOPACommittee @oncologytrainee @OncEd @OncologyNT @myESMO @WMidlandsCA @NHS_WMCA @cancer_east @uhbtrust @ECMC_UK @OncoViews @OncEdSpec

Join the NHS Wales Library Service and the NHS Wales E-Library for our literature searching webinar on Finding information using Embase. Aimed at those unconfident with literature searches or looking to refresh their skills. Thursday July 3rd - 10am @bb5628b8-e328-4082-a856-433c9edc8fae" target="_blank" rel="nofollow noopener">events.teams.microsoft.com/event/26e2e97b…

📚 "You feel like you've been useful, and that you've made your mark" At the end of March, we say a sad goodbye to Bernadette, who retires after 34 years as Velindre's librarian. Read more about Bernadette's fascinating career: 🔗 velindre.nhs.wales/news/latest-ne…

🚨 New #ImmunoBuddies Podcast! 🚨 🎙 All Skin Cancer Demystified 💡Is neoadjuvant immunotherapy really the panacea? Join us as we discuss with Prof. Axel Hauschild, Head of the Skin Cancer Trial Center, University Hospital Schleswig-Holstein, Campus Kiel, Germany. 🔗 Listen here: open.spotify.com/episode/1cGnV2… @UKSH_KI_HL @RickyFrazer1 @AOlssonBrown @IOClinicalNet @OncEd @myESMO @UKONSmember @UKAOSociety @BOPACommittee @focusonmelanoma @OncologyForum @OncologyNT @oncolo #Immunotherapy #SkinCancer #IOCN #ImmunoOncology

📢 #ThrowbackThursday with #ImmunoBuddies! Back in early summer 2023, we ran a 3-part series diving into neurological toxicities & Guillain-Barré syndrome in immunotherapy with Dr Mark Willis. 🧠💡 Fast forward to now—join the IOCN webinar on Tuesday, 4th March at 6:30 PM for the latest insights on neurological toxicities! 🖥️🔬 Catch up with the podcasts here: open.spotify.com/episode/5jI0I8… Sign up for the IOCN Webinar here: ticketsource.co.uk/booking/t-avnl… @IOClinicalNet @RickyFrazer1 @AOlssonBrown

🚨 New Podcast Alert! 🚨 Join us for our second podcast with @AdamJanuszewski as we dive into the role of immunotherapy in Mesothelioma. Don't miss this insightful discussion! 🎙️🔬 🎧Listen Here: open.spotify.com/episode/6DAL8p… #Immunotherapy #Mesothelioma #Oncology #IOCN @RickyFrazer1 @AOlssonBrown @UKONSmember @UKAOSociety @BOPACommittee @OncologyForum @myESMO

Pleased to share our latest validated search filters! The NICE AI medical device intervention filters (MEDLINE & Embase, Ovid) retrieve evidence about the interventions effectively and reliably: cambridge.org/core/journals/… #medlibs #ukmedlibs #canmedlibs #ausmedlibs @ISSG_Filters

THE BEST WEEK OF MY CAREER! Witnessing first hand the delivery of TILs in NIK. So excited to support bringing TILs to treat Solid Tumours for the first time in Wales and working to ensure our Welsh patients can access these treatment as they are approved! @MoondanceCancer

The JBI Manual for Evidence Synthesis has added a new chapter, 'Search Methodology for JBI Evidence Syntheses', providing essential guidance for academics and researchers to conduct systematic reviews and scoping reviews👉 ow.ly/OtOK50UezyO #JBIEBHC

So important that we make progress in identifying those likely to develop toxicity from immunotherapy. Fascinating work @curenetics @VelindreCS @VelindreTrust @Velindre @tomcrosby12 @JiffyRugby @DavidDonegan @AdvancedTxWales @immunobuddies @IOClinicalNet

Another rapid review carried out by Cardiff Evidence Synthesis Collaborative reporting impact @WCEBC_official @CsontiK @MrsDeborahE @lizzygillen @SysReviews @adriangkedwards

It is FINALLy here, the third and final part with @clpalles discussing the future of genetics and genomics in the use of immunotherapy! Our most popular short series to date! @IOClinicalNet @VelindreCC @VuMedi @OncologyForum @AOlssonBrown @AdvancedTxWales @lshubwales @MoondanceCancer @SBKHealthcare @Cardiffandvale